Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 6.25 GBX -0.79% Market Closed
Market Cap: 297.9m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Allergy Therapeutics PLC
Investor Relations

Allergy Therapeutics Plc is a biotechnology company. The company is headquartered in Worthing, West Sussex and currently employs 601 full-time employees. The company went IPO on 2004-10-11. The firm is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. The company sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Manuel Llobet
CEO & Executive Director
No Bio Available
Dr. Shaun Antony Furlong
CFO & Executive Director
No Bio Available
Dr. Murray Skinner
Chief Scientific Officer
No Bio Available
Ms. Sue Baker
Head of Human Resources
No Bio Available
Simon Piggott
Head of Clinical Science
No Bio Available
Alan Bullimore
Head of Communication & Market Development
No Bio Available
Mr. Russell Picket
Group Financial Controller
No Bio Available
Karley Charlotte Mouatt Cheesman
Company Secretary
No Bio Available
Mr. Matthew Heath
Principal Scientist
No Bio Available

Contacts

Address
WEST SUSSEX
WORTHING
Dominion Way
Contacts